Anti-Cystatin-A Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody targeting Cystatin-A (CSTA), an intracellular cysteine proteinase inhibitor involved in epidermal cell-cell adhesion and desmosome regulation.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-
UniProt
P01040
Size
100ug
Cat. #
RP1CystatinA

In stock

SKU
RP-CystatinA

Options

As low as: $130.00

Target Overview

Cystatin-A (CSTA, UniProt P01040), also known as Stefin-A, is a 98-amino acid intracellular cysteine proteinase inhibitor belonging to the stefin subfamily of cystatins. Unlike secreted cystatins, Cystatin-A is localized to the cytoplasm where it functions as a tight-binding reversible inhibitor of cysteine cathepsins, including cathepsins B, H, and L. Beyond its canonical protease inhibitory role, Cystatin-A participates in desmosome-mediated cell-cell adhesion in the lower levels of the epidermis, contributing to epidermal barrier integrity and keratinocyte differentiation. The protein is highly expressed in stratified squamous epithelia, including skin, esophagus, and oral mucosa. Researchers study Cystatin-A in contexts ranging from epithelial biology and wound healing to tumor progression, where altered expression has been documented in squamous cell carcinomas and other malignancies. Its role in regulating intracellular proteolysis and maintaining cellular architecture makes it a relevant target for investigations into inflammatory skin disorders, metaplastic epithelial responses, and cancer biology.

Background

Cystatin-A functions as a frontline regulator of intracellular proteolytic activity, providing protective control over cysteine cathepsin-mediated protein degradation in epithelial cells. Its expression is particularly abundant in terminally differentiating keratinocytes, where it contributes to the structural organization of the cornified envelope and modulates desmosomal adhesion complexes. Dysregulation of Cystatin-A has been implicated in pathological epithelial remodeling: recent work by Xie et al demonstrated that the SPRR2A-CSTA axis mediates IL-17A-induced squamous metaplasia and steroid resistance in allergic rhinitis, suggesting a role in inflammatory airway remodeling (PMID: 42269941). In oncology, Cystatin-A expression patterns vary by tumor type and stage. Wu et al reported that M2-like glioma-associated macrophages secrete CSTA to drive glioblastoma progression through an ITGB4-TGFB1 feedback mechanism, highlighting a tumor-promoting secreted function distinct from its canonical intracellular inhibitory role (PMID: 41832564). Conversely, loss of Cystatin-A expression has been observed in some epithelial cancers, potentially contributing to dysregulated cathepsin activity and enhanced invasive capacity. Emerging data also position Cystatin-A as a biomarker in systemic inflammatory conditions. Shen et al identified CSTA as a potential regulator of ferroptosis in sepsis, with diagnostic value for patient stratification (PMID: 41952180). The protein's involvement in cell death pathways, protease regulation, and intercellular signaling continues to expand its relevance across disciplines, from dermatology and pulmonology to critical care and neuro-oncology.

References

  1. Xie S et al (2026) The SPRR2A-CSTA Axis Drives IL-17A-Induced Squamous Metaplasia and Steroid Resistance in Allergic Rhinitis. J Allergy Clin Immunol. PubMed · DOI
  2. Wu J et al (2026) M2-like GAMs secreting CSTA drive glioblastoma progression via the ITGB4-TGFB1 feedback axis. J Transl Med. PubMed · DOI
  3. Shen X et al (2026) CSTA and DDX24: potential biomarkers regulating ferroptosis in sepsis and their diagnostic value. BMC Med Genomics. PubMed · DOI

Additional Specifications

Gene Symbol CSTA
UniProt ID P01040
Host Species Rabbit
Species Reactivity Validated- Human
Potential-
Pack Size 100ug
Immunogen (Aminoterminus and alpha helix domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-51.
Immunogen (Cartboxyterminus)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 48-98.
Alternate Names CSTA, Cystatin-AS, Stefin-A, Stefin A

Frequently Asked Questions

What molecular weight band should I expect for Cystatin-A on Western blot?

Cystatin-A migrates at approximately 11 kDa on reducing SDS-PAGE, consistent with its 98-amino acid sequence. Because the protein lacks post-translational glycosylation and remains predominantly cytoplasmic, you should see a single clean band in epithelial-rich samples. In keratinocyte lysates or stratified squamous tissue homogenates, expect strong signal intensity. Degradation products occasionally appear below 11 kDa if samples were not processed quickly with protease inhibitors, given that Cystatin-A itself regulates cysteine cathepsins that can act on cellular proteins during lysis.

What is the recommended starting dilution for this Cystatin-A antibody in Western blot?

Start at 1:1000 dilution in blocking buffer for Western blot, which has been validated with this rabbit polyclonal antibody. Depending on expression levels in your sample and detection system sensitivity, the working range typically falls between 1:500 and 1:2000. Epidermal keratinocyte lysates and oral mucosa samples generally yield robust signal at 1:1000, while tissues with lower Cystatin-A expression may benefit from 1:500. Always include a positive control lysate from human epidermis or esophageal epithelium to confirm antibody performance before troubleshooting dilution with experimental samples.

Does this antibody cross-react with other cystatin family members like Cystatin-B or Cystatin-C?

This antibody was raised against Cystatin-A and shows validated specificity for human CSTA. Cystatin-B (Stefin-B) shares approximately 50 percent sequence identity with Cystatin-A within the stefin subfamily, but immunogen selection minimizes cross-reactivity risk. Cystatin-C belongs to a different subfamily, is secreted rather than cytoplasmic, and has lower homology. We have not observed cross-reactivity with Cystatins B or C in validation experiments, but if you work with samples expressing multiple stefins at high levels, consider running recombinant Cystatin-B alongside your samples as a specificity control.

Which human tissues or cell lines serve as good positive controls for Cystatin-A expression?

Primary human keratinocytes, HaCaT cells, or tissue lysates from stratified squamous epithelia provide reliable positive controls. Cystatin-A is highly abundant in epidermis, particularly in the lower spinous and basal layers, as well as in esophageal and oral mucosal epithelium. If working with cell lines, HaCaT spontaneously immortalized keratinocytes express robust Cystatin-A. Avoid using fibroblasts, lymphocytes, or most mesenchymal cell types as positive controls since expression is minimal. For IHC, normal human skin sections serve as an ideal positive tissue control, with expected cytoplasmic staining in keratinocytes.

Is this Cystatin-A antibody validated for mouse or rat samples?

This antibody has been validated for human samples. Cross-reactivity with mouse or rat Cystatin-A is predicted based on sequence homology—murine and rat orthologs share approximately 70 to 75 percent identity with human CSTA—but we have not formally validated reactivity in these species. If you plan to use mouse or rat samples, treat this as experimental and include appropriate positive controls such as mouse epidermis or esophageal tissue. Test at the recommended 1:1000 dilution initially, and verify band size and specificity with a blocking peptide or siRNA knockdown if signal is ambiguous.

Can I use this antibody for immunofluorescence or immunohistochemistry on paraffin sections?

Yes, Triple Point Biologics antibodies are validated for Western blot; immunofluorescence and IHC application data is in progress in addition to Western blot. For IHC on formalin-fixed paraffin-embedded sections, antigen retrieval is typically required—citrate buffer at pH 6.0 with heat-mediated retrieval works well for Cystatin-A. Expect cytoplasmic staining in keratinocytes and stratified squamous epithelia. Start with a 1:100 to 1:200 dilution for IHC and IF; optimal concentration depends on your detection system and tissue fixation time. Include adjacent serial sections as negative controls using preimmune rabbit IgG at matched concentration.

Should I add protease inhibitors when preparing lysates for Cystatin-A Western blot?

Yes, include a broad-spectrum protease inhibitor cocktail during lysis. Although Cystatin-A is a protease inhibitor itself, it specifically targets cysteine cathepsins, and your sample will contain serine, aspartyl, and metalloproteases that can degrade cellular proteins during extraction. Cysteine cathepsins released during cell disruption may also act on other targets before Cystatin-A re-equilibrates in dilute lysate. Work quickly on ice, snap-freeze samples if not analyzing immediately, and avoid multiple freeze-thaw cycles. This practice ensures you detect intact 11 kDa Cystatin-A rather than degradation fragments.

How should I store this Cystatin-A antibody and what is the expected shelf life?

Store the antibody at -20°C in undiluted aliquots to maintain long-term stability. Avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregate formation. For frequent use, prepare working aliquots and keep one at 4°C with 0.02 to 0.05 percent sodium azide as preservative for up to one month. The 100 µg pack size is suitable for extensive experimental series. Polyclonal antibodies from immunized rabbits, when stored properly at -20°C, typically retain activity for two to three years from production date. Check the product vial label for the specific lot expiration date.

Western blot validation for RP-CystatinA — 2 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Cystatin-A: Aminoterminus and alpha helix domain — WB validation
WB · Panel 1 Cystatin-A: Aminoterminus and alpha helix domain
Cystatin-A: Cartboxyterminus — WB validation
WB · Panel 2 Cystatin-A: Cartboxyterminus

Custom validation studies available on request — contact us.

Also known as:

  • CSTA
  • Cystatin-AS
  • Stefin-A
  • Stefin A
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →